BioCentury
ARTICLE | Clinical News

BI 695501: Ph III data

January 20, 2017 9:33 PM UTC

Last October, Boehringer reported top-line data from a double-blind, international Phase III trial in 645 patients with moderate to severe active RA who were treated with methotrexate showing that BI ...

BCIQ Company Profiles

Boehringer Ingelheim GmbH